J Korean Diabetes.  2023 Jun;24(2):76-83. 10.4093/jkd.2023.24.2.76.

Screening Test for Evaluation of Cardiovascular Disease in Patients with Diabetes

• Mok JO
• Jung CH

• KMID: 2544520
• DOI: http://doi.org/10.4093/jkd.2023.24.2.76

Abstract

Diabetes mellitus (DM) per se confers a two-fold excess risk of vascular outcomes, but the risk is subject to wide variation depending on the population and contemporary prophylactic medical therapy. Although patients with DM have a high rate of asymptomatic coronary heart disease (CHD), routine screening for CHD has not been shown to improve clinical outcomes in asymptomatic DM patients being treated with intensive medical therapy for cardiovascular risk factors. Therefore, professional societies do not recommend routine screening for CHD in asymptomatic patients. However, they recommend additional imaging such as coronary calcium score or carotid ultrasonography to provide risk reclassification and reason for treatment intensification. In this review, we provide recent guidelines regarding screening for cardiovascular disease in asymptomatic DM patients and updated the discussion of the role of electrocardiography, coronary calcium score, and carotid ultrasonography.

Keyword

Cardiovascular diseases; Coronary artery calcium score; Diabetes mellitus; Screening; Ultrasonography; carotid arteries

Reference

1.Clerc OF., Fuchs TA., Stehli J., Benz DC., Gräni C., Mes-serli M, et al. Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials. Eur Heart J Cardiovasc Imaging. 2018. 19:838–46.

2.Young LH., Wackers FJ., Chyun DA., Davey JA., Barrett EJ., Taillefer R., DIAD Investigators, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009. 301:1547–55.

3.Muhlestein JB., Lappé DL., Lima JA., Rosen BD., May HT., Knight S, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FAC-TOR-64 randomized clinical trial. JAMA. 2014. 312:2234–43.

4.Turrini F., Scarlini S., Mannucci C., Messora R., Giovanardi P., Magnavacchi P, et al. Does coronary atherosclerosis deserve to be diagnosed early in diabetic patients? The DADDY-D trial. Screening diabetic patients for unknown coronary disease. Eur J Intern Med. 2015. 26:407–13.

5.Rawshani A., Rawshani A., Franzén S., Sattar N., Eliasson B., Svensson AM, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018. 379:633–44.

6.Tandon S., Wackers FJ., Inzucchi SE., Bansal S., Staib LH., Chyun DA., DIAD Investigators, et al. Gender-based di-vergence of cardiovascular outcomes in asymptomatic patients with type 2 diabetes: results from the DIAD study. Diab Vasc Dis Res. 2012. 9:124–30.

7.ElSayed NA., Aleppo G., Aroda VR., Bannuru RR., Brown FM., Bruemmer D, et al. 10. Cardiovascular disease and risk management: Standards of Care in Diabetes-2023. Diabetes Care. 2023. 46(suppl 1):S158–90. Erratum in: Diabetes Care 2023;46: 898.

8.Cosentino F., Grant PJ., Aboyans V., Bailey CJ., Ceriello A., Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020. 41:255–323. Erratum in: Eur Heart J 2020;41: 4317.

9.Valensi P., Henry P., Boccara F., Cosson E., Prevost G., Em-merich J, et al. Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: position paper of the French Society of Cardiol-ogy and the French-speaking Society of Diabetology. Arch Cardiovasc Dis. 2021. 114:150–72.

10.Hur KY., Moon MK., Park JS., Kim SK., Lee SH., Yun JS, et al. 2021 Clinical practice guidelines for diabetes mellitus of the Korean Diabetes Association. Diabetes Metab J. 2021. 45:461–81.

11.Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in non-insulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Am J Cardiol. 1997. 79:134–9.

12.Gupta S., Gupta RK., Kulshrestha M., Chaudhary RR. Evaluation of ECG abnormalities in patients with asymptomatic type 2 diabetes mellitus. J Clin Diagn Res. 2017. 11:OC39–41.

13.Harms PP., van der Heijden AA., Rutters F., Tan HL., Beu-lens JWJ., Nijpels G, et al. Prevalence of ECG abnormalities in people with type 2 diabetes: the Hoorn Diabetes Care System cohort. J Diabetes Complications. 2021. 35:107810.

14.Valensi P., Lorgis L., Cottin Y. Prevalence, incidence, pre-dictive factors and prognosis of silent myocardial infarction: a review of the literature. Arch Cardiovasc Dis. 2011. 104:178–88.

15.Stettler C., Bearth A., Allemann S., Zwahlen M., Zanchin L., Deplazes M, et al. QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia. 2007. 50:186–94.

16.Jonas DE., Reddy S., Middleton JC., Barclay C., Green J., Baker C, et al. Screening for cardiovascular disease risk with resting or exercise electrocardiography: evidence re-port and systematic review for the US preventive services task force. JAMA. 2018. 319:2315–28.

17.Poirier P., Bertrand OF., Leipsic J., Mancini GBJ., Raggi P., Roussin A. Screening for the presence of cardiovascular disease. Can J Diabetes. 2018. 42(Suppl 1):S170–7.

18.Acampa W., Petretta M., Daniele S., Del Prete G., Assante R., Zampella E, et al. Incremental prognostic value of stress myocardial perfusion imaging in asymptomatic diabetic patients. Atherosclerosis. 2013. 227:307–12.

19.Scognamiglio R., Negut C., Ramondo A., Tiengo A., Avo-garo A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2006. 47:65–71.

20.Lee DP., Fearon WF., Froelicher VF. Clinical utility of the exercise ECG in patients with diabetes and chest pain. Chest. 2001. 119:1576–81.

21.Zellweger MJ., Hachamovitch R., Kang X., Hayes SW., Friedman JD., Germano G, et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J. 2004. 25:543–50.

22.Agatston AS., Janowitz WR., Hildner FJ., Zusmer NR., Via-monte M Jr., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990. 15:827–32.

23.Malik S., Zhao Y., Budoff M., Nasir K., Blumenthal RS., Bertoni AG, et al. Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multiethnic study of atherosclerosis. JAMA Cardiol. 2017. 2:1332–40.

24.Takamura K., Fujimoto S., Mita T., Kawaguchi YO., Kurita M., Kadowaki S, et al. Identification of risk factors for coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Clin Med. 2022. 11:1226.

25.Valenti V., BÓ Hartaigh., Cho I., Schulman-Marcus J., Gran-sar H., Heo R, et al. Absence of coronary artery calcium identifies asymptomatic diabetic individuals at low near-term but not long-term risk of mortality: a 15-year fol-low-up study of 9715 patients. Circ Cardiovasc Imaging. 2016. 9:e003528.

26.Gottlieb I., Miller JM., Arbab-Zadeh A., Dewey M., Clouse ME., Sara L, et al. The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for con-ventional coronary angiography. J Am Coll Cardiol. 2010. 55:627–34.

27.Martin SS., Blaha MJ., Blankstein R., Agatston A., Rivera JJ., Virani SS, et al. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: impli-cations for statin therapy from the multiethnic study of atherosclerosis. Circulation. 2014. 129:77–86.

28.Cardoso R., Dudum R., Ferraro RA., Bittencourt M., Blankstein R., Blaha MJ, et al. Cardiac computed tomography for personalized management of patients with type 2 diabetes mellitus. Circ Cardiovasc Imaging. 2020. 13:e011365.

29.Cainzos-Achirica M., Miedema MD., McEvoy JW., Al Rifai M., Greenland P., Dardari Z, et al. Coronary artery calcium for personalized allocation of aspirin in primary prevention of cardiovascular disease in 2019: the MESA Study (Multi-Ethnic Study of Atherosclerosis). Circulation. 2020. 141:1541–53.

30.Hecht H., Blaha MJ., Berman DS., Nasir K., Budoff M., Leipsic J, et al. Clinical indications for coronary artery calcium scoring in asymptomatic patients: expert consensus statement from the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr. 2017. 11:157–68.

31.Budoff M., Backlund JC., Bluemke DA., Polak J., Bebu I., Schade D, et al. The association of coronary artery calcification with subsequent incidence of cardiovascular disease in type 1 diabetes: the DCCT/EDIC trials. JACC Cardiovasc Imaging. 2019. 12(7 Pt 2):1341–9.

32.Stein JH., Korcarz CE., Hurst RT., Lonn E., Kendall CB., Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thick-ness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008. 21:93–111. quiz 189-90. Erratum in: J Am Soc Echocardiogr 2008;21: 376.

33.Katakami N., Matsuoka TA., Shimomura I. Clinical utility of carotid ultrasonography: application for the management of patients with diabetes. J Diabetes Investig. 2019. 10:883–98.

34.Grønholdt ML., Nordestgaard BG., Schroeder TV., Vor-strup S., Sillesen H. Ultrasonic echolucent carotid plaques predict future strokes. Circulation. 2001. 104:68–73.

35.Troyer A., Saloner D., Pan XM., Velez P., Rapp JH; Assessment of Carotid Stenosis by Comparison with Endarterectomy Plaque Trial Investigators. Major carotid plaque surface irregularities correlate with neurologic symptoms. J Vasc Surg. 2002. 35:741–7.

36.Geroulakos G., Ramaswami G., Nicolaides A., James K., Labropoulos N., Belcaro G, et al. Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg. 1993. 80:1274–7.

37.Grant EG., Benson CB., Moneta GL., Alexandrov AV., Baker JD., Bluth EI, et al. Carotid artery stenosis: grayscale and Doppler US diagnosis-Society of Radiologists in Ultra-sound Consensus Conference. Radiology. 2003. 229:340–6.

38.Malik S., Budoff MJ., Katz R., Blumenthal RS., Bertoni AG., Nasir K, et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multiethnic study of atherosclerosis. Diabetes Care. 2011. 34:2285–90.

39.Akazawa S., Tojikubo M., Nakano Y., Nakamura S., Tamai H., Yonemoto K, et al. Usefulness of carotid plaque (sum and maximum of plaque thickness) in combination with inti-ma-media thickness for the detection of coronary artery disease in asymptomatic patients with diabetes. J Diabetes Investig. 2016. 7:396–403.